Disposition of tradable shares by King Adam of Qsam Biosciences at 9.62 subject to Rule 16b-3

QSAMDelisted Stock  USD 4.49  0.05  1.13%   
About 50% of Qsam Biosciences' investors are presently thinking to get in. The analysis of current outlook of investing in Qsam Biosciences suggests that some traders are interested regarding Qsam Biosciences' prospects. Qsam Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Qsam Biosciences. Many technical investors use Qsam Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Qsam Biosciences otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Qsam daily returns and investor perception about the current price of Qsam Biosciences as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Qsam Biosciences Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 11 common stock at 9.62 of Qsam Biosciences by King Adam on 2nd of May 2024. This event was filed by Qsam Biosciences with SEC on 2024-05-02. Statement of changes in beneficial ownership - SEC Form 4

Qsam Biosciences Fundamental Analysis

We analyze Qsam Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qsam Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qsam Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Qsam Biosciences is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Qsam Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Qsam Biosciences otc stock to make a market-neutral strategy. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics with similar companies.

Peers

Qsam Biosciences Related Equities

LCTXLineage Cell   5.00   
0%
81.0%
CVKDCadrenal Therapeutics,   3.89   
0%
63.0%
APVOAptevo Therapeutics   1.83   
0%
29.0%
ACHLAchilles Therapeutics   0.89   
0%
14.0%
ICCCImmuCell   0.74   
0%
12.0%
ENLVEnlivex Therapeutics   0.90   
14.0%
0%
PMVPPmv Pharmaceuticals   1.39   
22.0%
0%
DMACDiaMedica Therapeutics   1.54   
25.0%
0%
FBIOPFortress Biotech   1.68   
27.0%
0%
ASMBAssembly Biosciences   2.91   
47.0%
0%
CTMXCytomX Therapeutics   3.41   
55.0%
0%
NUVBNuvation Bio   3.75   
60.0%
0%
MRKRMarker Therapeutics   4.17   
67.0%
0%
ONTTFOxford Nanopore   5.49   
89.0%
0%
SNPXSynaptogenix   6.16   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Qsam OTC Stock

If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation